We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+5.4%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.89B
AUM Growth
+$72.5M
Cap. Flow
+$60.2M
Cap. Flow %
3.19%
Top 10 Hldgs %
37.36%
Holding
2,292
New
978
Increased
275
Reduced
231
Closed
802

Sector Composition

Rank Sector Weight
1 Communication Services 23.21%
2 Financials 17.2%
3 Technology 13.4%
4 Healthcare 6.24%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQB icon
1401
AquaBounty Technologies
AQB
$7.67M
$8K ﹤0.01%
+13,560
New +$13.3K
CAPT
1402
DELISTED
Captivision
CAPT
$8K ﹤0.01%
+10,825
New +$13.2K
CDT icon
1403
CDT Equity Inc
CDT
$1.87M
0
DRIO icon
1404
DarioHealth
DRIO
$74.8M
$8K ﹤0.01%
+514
New +$8.89K
MDAIW icon
1405
Spectral AI Warrants
MDAIW
$5.56M
$8K ﹤0.01%
+10,321
New +$2.79K
MEGL icon
1406
Magic Empire Global Ltd
MEGL
$6.13M
$8K ﹤0.01%
+3,709
New +$7.64K
OMH icon
1407
Ohmyhome Ltd
OMH
$3.26M
$8K ﹤0.01%
+2,028
New +$8.22K
VGZ icon
1408
Vista Gold
VGZ
$331M
$8K ﹤0.01%
+13,968
New +$8.83K
ZKIN icon
1409
ZK International Group
ZKIN
$61.3M
$8K ﹤0.01%
+1,881
New +$7.8K
SYRS
1410
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$8K ﹤0.01%
32,791
+13,162
+67% +$15.8K
CARM
1411
DELISTED
Carisma Therapeutics
CARM
$7K ﹤0.01%
+17,327
New +$14.3K
HCWB icon
1412
HCW Biologics
HCWB
$5.06M
$7K ﹤0.01%
+65
New +$7.58K
PZG icon
1413
Paramount Gold Nevada
PZG
$132M
$7K ﹤0.01%
+19,140
New +$7.42K
SATLW icon
1414
Satellogic Inc Warrant
SATLW
$108M
$7K ﹤0.01%
+18,772
New +$4.45K
OLOX
1415
Olenox Industries
OLOX
$4.45M
$7K ﹤0.01%
+22
New +$10.5K
SHFS icon
1416
SHF Holdings
SHFS
$1.13M
$7K ﹤0.01%
+761
New +$6.39K
TSBX
1417
DELISTED
Turnstone Biologics
TSBX
$7K ﹤0.01%
+14,810
New +$7.32K
UWMC.WS
1418
DELISTED
UWM Holdings Warrants
UWMC.WS
$7K ﹤0.01%
+35,647
New +$8.54K
VNRX icon
1419
VolitionRx Ltd
VNRX
$8.61M
$7K ﹤0.01%
+612
New +$8.21K
AIM
1420
AIM ImmunoTech
AIM
$7.06M
$7K ﹤0.01%
367
-655
-64% -$15.3K
BTAI icon
1421
BioXcel Therapeutics
BTAI
$28.8M
$6K ﹤0.01%
+1,061
New +$8.86K
FTFT icon
1422
Future FinTech Group
FTFT
$1.56M
$6K ﹤0.01%
+120
New +$6.71K
HYFM icon
1423
Hydrofarm Holdings
HYFM
$7.96M
$6K ﹤0.01%
1,089
-12,971
-92% -$84.7K
INAB icon
1424
IN8bio
INAB
$10.3M
$6K ﹤0.01%
733
-1,027
-58% -$9.02K
PASG icon
1425
Passage Bio
PASG
$14.5M
$6K ﹤0.01%
+514
New +$6.69K

Similar funds

Virtu Financial's Q4 2024 Portfolio in Review

As of Q4 2024, Virtu Financial held 2,292 positions worth $1.89B, up 4% from $1.82B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Virtu Financial deployed $60.2M of net new capital in Q4 2024, opening 978 new positions and adding to 275 existing holdings. Its largest new stake was Apple: 75,436 shares worth $18.9M.

By sector, the portfolio is most concentrated in Communication Services at 23% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $206M trimmed.

  • Virtu Financial's largest Q4 2024 buy was Apple: 75,436 shares worth $18.9M.
  • Virtu Financial added most to Alphabet (Google) Class A in Q4 2024, an estimated $68.6M increase.
  • Virtu Financial's biggest Q4 2024 reduction was Berkshire Hathaway Class A, cutting an estimated $206M.
  • Virtu Financial fully exited Strategy Inc in Q4 2024, selling an estimated $37.8M.
  • Virtu Financial's ten largest holdings make up 37% of its $1.89B portfolio in Q4 2024.
  • Virtu Financial opened 978 new positions and closed 802 in Q4 2024.
  • Virtu Financial's portfolio value rose 4% quarter-over-quarter to $1.89B.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.